Recent News

Cook IVC Filter Settlement Conference May Be Postponed

Posted on February 12, 2016 by Sandy Liebhard

Cook Medical, Inc. is seeking to postpone a Settlement Conference in the multidistrict litigation involving the company’s Celect and Gunther Tulip IVC filters. Court records indicate that the Conference was scheduled to be convened next month, from March 22nd through … Continue reading →

Levaquin Lawsuit News: Pennsylvania Court Rejects Mass Tort for Antibiotic Peripheral Neuropathy Claims

Posted on February 8, 2016 by Sandy Liebhard

A Pennsylvania state court has rejected a motion to have all peripheral neuropathy lawsuits filed in the state against the manufacturers of Levaquin, Cipro and Avelox centralized in a single mass tort proceeding. A single-paragraph order issued last week in … Continue reading →

Morcellator Lawsuit News: Federal Court Gives Priority to “In Extremis” Ethicon Cases

Posted on February 4, 2016 by Sandy Liebhard

Pretrial discovery is now underway in the federal multidistrict litigation involving nearly three dozen power morcellator lawsuits filed against Ethicon, Inc. According to an Order issued in the U.S. District Court, District of Kansas, on January 4th, priority will be … Continue reading →

Bair Hugger Lawsuits Climb, as Federal Litigation Schedules Initial Conference

Posted on February 1, 2016 by Sandy Liebhard

Hip and knee replacement infection lawsuits involving the 3M Bair Hugger forced air warming blanket are continuing to mount in courts around the country. Meanwhile, the federal multidistrict litigation established late last year to handle these claims is preparing to … Continue reading →

Levaquin Side Effects Prompt RICO Lawsuit Filing

Posted on January 29, 2016 by Sandy Liebhard

Johnson & Johnson and its Janssen Pharmaceutical unit have been named in a RICO lawsuit that accuses the companies of concealing side effects associated with Levaquin. The complaint seeks $800 million in compensatory and punitive damages. The federal Racketeer Influenced … Continue reading →

Proposal Would Allow Bard IVC Filter Lawsuits to Head to Trial Next Year

Posted on January 28, 2016 by Sandy Liebhard

A proposal put forth by parties involved in the C.R. Bard IVC filter litigation would allow some cases to head to trial as early as next year. According to a Joint Report filed with the U.S. District Court, District of … Continue reading →

Zofran Lawsuit Defendant Thwarted in Dismissal Attempt

Posted on January 27, 2016 by Sandy Liebhard

GlaxoSmithKline has been unsuccessful in an attempt to dismiss hundreds of Zofran lawsuits filed on behalf of children who allegedly suffered birth defects related to their mother’s use of the medication in early pregnancy. In an Order issued in the … Continue reading →

Abilify Adverse Event Reports Include 100+ Cases of Pathological Gambling

Posted on January 25, 2016 by Sandy Liebhard

Reports linking Abilify to pathological gambling continue to mount, according to new data compiled by the Institute for Safe Medication Practices (ISMP). According to the group’s latest QuarterWatch Report, 147 adverse events involving Abilify and compulsive gambling were reported to … Continue reading →

Analysis Finds Invokana, Other SGLT2 Inhibitor Diabetes Drugs Increasingly Linked to Ketoacidosis

Posted on January 22, 2016 by Sandy Liebhard

A new analysis conducted by a prominent medical group has linked SGLT2 inhibitors like Invokana to hundreds of reports of metabolic ketoacidosis, also known as diabetic ketoacidosis. This potentially life-threatening condition has already been the subject of two U.S. Food … Continue reading →

Federal Bair Hugger Litigation Issues First Pretrial Order

Posted on January 19, 2016 by Sandy Liebhard

The federal litigation established for what could be thousands of hip and knee replacement infection lawsuits involving the 3M Bair Hugger forced air warming blanket is officially underway. The first Pretrial Order has been issued in the proceeding, and indicates … Continue reading →